Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Journal of the American Chemical Society
|
February 3, 2005
Oligomeric rods of alkyl- and hydridogallium imides
Bethany L Kormos, Jolin A Jegier, Paul C Ewbank, et al.
Journal of Medicinal Chemistry
|
November 14, 2013
Improving the odds of success in drug discovery: choosing the best compounds for in vivo toxicology studies
Travis T Wager, Bethany L Kormos, Joseph T Brady, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 10, 2015
Identification of Phosphorylation Consensus Sequences and Endogenous Neuronal Substrates of the Psychiatric Risk Kinase TNIK
Qi Wang, Stephen P Amato, David M Rubitski, et al.
Nature Chemical Biology
|
December 12, 2017
Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs
John D McCorvy, Kyle V Butler, Brendan Kelly, et al.
Scientific Reports
|
April 11, 2019
Author Correction: Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs
Noelia Ferruz, Stefan Doerr, Michelle A Vanase-Frawley, et al.
Scientific Reports
|
January 19, 2018
Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs
Noelia Ferruz, Stefan Doerr, Michelle A Vanase-Frawley, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 13, 2014
Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-b]pyridazine scaffold
Paul Galatsis, Jaclyn L Henderson, Bethany L Kormos, et al.
The Journal of Biological Chemistry
|
January 30, 2023
Structural studies identify angiotensin II receptor blocker-like compounds as branched-chain ketoacid dehydrogenase kinase inhibitors
Shenping Liu, Bethany L Kormos, John D Knafels, et al.
Journal of Medicinal Chemistry
|
October 30, 2014
Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor
Jaclyn L Henderson, Bethany L Kormos, Matthew M Hayward, et al.
ACS Chemical Neuroscience
|
October 8, 2016
Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects
Travis T Wager, Thomas Chappie, David Horton, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Journal of the American Chemical Society
|
February 3, 2005
Oligomeric rods of alkyl- and hydridogallium imides
Bethany L Kormos, Jolin A Jegier, Paul C Ewbank, et al.
Journal of Medicinal Chemistry
|
November 14, 2013
Improving the odds of success in drug discovery: choosing the best compounds for in vivo toxicology studies
Travis T Wager, Bethany L Kormos, Joseph T Brady, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 10, 2015
Identification of Phosphorylation Consensus Sequences and Endogenous Neuronal Substrates of the Psychiatric Risk Kinase TNIK
Qi Wang, Stephen P Amato, David M Rubitski, et al.
Nature Chemical Biology
|
December 12, 2017
Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs
John D McCorvy, Kyle V Butler, Brendan Kelly, et al.
Scientific Reports
|
April 11, 2019
Author Correction: Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs
Noelia Ferruz, Stefan Doerr, Michelle A Vanase-Frawley, et al.
Scientific Reports
|
January 19, 2018
Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs
Noelia Ferruz, Stefan Doerr, Michelle A Vanase-Frawley, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 13, 2014
Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-b]pyridazine scaffold
Paul Galatsis, Jaclyn L Henderson, Bethany L Kormos, et al.
The Journal of Biological Chemistry
|
January 30, 2023
Structural studies identify angiotensin II receptor blocker-like compounds as branched-chain ketoacid dehydrogenase kinase inhibitors
Shenping Liu, Bethany L Kormos, John D Knafels, et al.
Journal of Medicinal Chemistry
|
October 30, 2014
Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor
Jaclyn L Henderson, Bethany L Kormos, Matthew M Hayward, et al.
ACS Chemical Neuroscience
|
October 8, 2016
Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects
Travis T Wager, Thomas Chappie, David Horton, et al.
Page
of 3